JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 7 May 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.00675-08v1
82/14/7059    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Sanders, R. L.
Right arrow Articles by Spector, D. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders, R. L.
Right arrow Articles by Spector, D. H.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.00675-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Development of Cell Lines that Provide Tightly Controlled Temporal Translation of the Human Cytomegalovirus IE2 Proteins for Complementation and Functional Analyses of Growth-Impaired and Non-Viable IE2 Mutant Viruses

Rebecca L. Sanders, Charles L. Clark, Christopher S. Morello, and Deborah H. Spector*

Department of Cellular and Molecular Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, and Division of Biological Sciences, University of California, San Diego, La Jolla, California 92093-0712

* To whom correspondence should be addressed. Email: dspector{at}ucsd.edu.


   Abstract

The human cytomegalovirus IE2 86 protein is essential for viral replication. Two other proteins, IE2 60 and IE2 40, which arise from the C-terminal half of IE2 86, are important for later stages of the infection. Functional analyses of IE2 86 in the context of the infection have utilized bacterial artificial chromosomes as vectors to generate mutant viruses. One limitation is that many mutations result in debilitated or non-viable viruses. Here, we describe a novel system that allows tightly controlled temporal expression of the IE2 proteins, and provides complementation of both growth-impaired and non-viable IE2 mutant viruses. The strategy involves creation of cell lines with separate lentiviruses expressing a bicistronic RNA with a selectable marker as the first ORF, and IE2 86, IE2 60, or IE2 40 as the second ORF. Induction of expression of the IE2 proteins occurs only following DNA recombination events mediated by Cre and FLP recombinases that delete the first ORF. HCMV encodes Cre and FLP, which are expressed at immediate-early (for IE2 86) and early-late times (for IE2 40 and IE2 60), respectively. We show that the presence of full-length IE2 86 alone provides some complementation for virus production, but the correct temporal expression of IE2 86 and IE2 40 together has the most beneficial effect for early-late gene expression and synthesis of infectious virus. This approach for inducible protein translation can be used for complementation of other mutations as well as controlled expression of toxic cellular and microbial proteins.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.